Analysis and design of randomised clinical trials involving competing risks endpoints
about
Quantifying intrinsic and extrinsic control of single-cell fates in cancer and stem/progenitor cell pedigrees with competing risks analysisStatistical issues in the analysis of adverse events in time-to-event data.Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study.Psychiatric Predictors of Long-term Transplant-Related Outcomes in Lung Transplant RecipientsThe association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation ProgramApplying competing risks regression models: an overview.Extensive peritoneal lavage after curative gastrectomy for gastric cancer (EXPEL): study protocol of an international multicentre randomised controlled trial.The influence of hypophosphatemia on outcomes of low- and high-intensity continuous renal replacement therapy in critically ill patients with acute kidney injury.Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challenges.All-cause and cause-specific mortality after hip fracture among Chinese women and men: the Singapore Chinese Health Study.Estimating sample size in the presence of competing risks - Cause-specific hazard or cumulative incidence approach?
P2860
Q27348389-0BB8572E-319A-4237-A6D8-4A75E85B1E0AQ31050713-8A4D48E5-06B6-4492-94A8-DB5EE2D138E9Q34630887-2AC59333-E109-4815-94DB-33CB3827DF4CQ36385117-A106D7DF-733C-4528-A3A8-8CC57360F243Q36666443-67E7CCF8-4E5C-44C3-99FD-DF6EBC54A2EEQ38046436-4AEB1B95-2BEC-4CB9-9CE2-E90A46E88F77Q38973837-E8156AF6-185F-4324-9A6A-400D494321CEQ41387219-772EDA41-C910-4B83-B9D7-8B0187349B49Q42617661-35EE67B3-940C-4B7D-B268-0F7247442817Q45143171-2F90F756-50EC-4886-B70B-D26FE3E89EDFQ47337078-51FCB02F-47C9-4D23-ACB6-AECD9518991A
P2860
Analysis and design of randomised clinical trials involving competing risks endpoints
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Analysis and design of randomised clinical trials involving competing risks endpoints
@ast
Analysis and design of randomised clinical trials involving competing risks endpoints
@en
type
label
Analysis and design of randomised clinical trials involving competing risks endpoints
@ast
Analysis and design of randomised clinical trials involving competing risks endpoints
@en
prefLabel
Analysis and design of randomised clinical trials involving competing risks endpoints
@ast
Analysis and design of randomised clinical trials involving competing risks endpoints
@en
P2093
P2860
P356
P1433
P1476
Analysis and design of randomised clinical trials involving competing risks endpoints
@en
P2093
Bee-Choo Tai
David Machin
Joseph Wee
P2860
P2888
P356
10.1186/1745-6215-12-127
P577
2011-05-19T00:00:00Z
P5875
P6179
1008693737